BIOMEKANIKK AS
BIOMEKANIKK AS is registered as a limited company in Oslo, Oslo with organisation number 991707417. The business is classified under activities of agents involved in the wholesale of other particular products (NACE 46.180). The company was incorporated in 2007. Registered share capital is NOK 105,000, divided into 210000 shares. The company's stated purpose is: “Selskapets formål er fremstilling/salg av biomekanisk testutstyr og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.”. The most recent filed accounts, for the 2025 financial year, show NOK 599,000 in revenue and NOK 268,000 in operating profit.
Key figures · 2025
Financial health · 2025
Who owns BIOMEKANIKK AS?
BIOMEKANIKK AS has 3 registered shareholders:
- EINAR-ANDRE RIVELAND BYDAL 33.3%
- VIDAR EIVIND JAKOBSEN 33.3%
- THOMAS ARTHUR JONSKÅS JAKOBSEN 33.3%
Which companies does BIOMEKANIKK AS own?
BIOMEKANIKK AS holds a stake in 1 company:
- NECKGRAPH AS 100.0%
Group structure
BIOMEKANIKK AS er morselskap for 1 datterselskap:
- NECKGRAPH AS 100%
Frequently asked questions about BIOMEKANIKK AS
Who owns BIOMEKANIKK AS?
EINAR-ANDRE RIVELAND BYDAL is the largest registered owner, with 33.3%.
What is the revenue of BIOMEKANIKK AS?
BIOMEKANIKK AS had revenue of NOK 599,000 in 2025.
Who is the general manager of BIOMEKANIKK AS?
Vidar Eivind Jakobsen is registered as general manager of BIOMEKANIKK AS.
Where is BIOMEKANIKK AS based?
BIOMEKANIKK AS has its business address in Oslo.
Property
3 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.